Explore how ChemAIRS® AI retrosynthesis software analyzes the synthesis of aleniglipron (GSBR-1290), comparing a 21-step patent route with a proposed 15-step alternative. Discover how AI-powered synthetic route planning can identify shorter pathways, evaluate reaction risks, and support more informed decisions in medicinal and process chemistry.